Mylan Elidel 10 mg/g cream

Elidel is a pharmaceutical cream containing pimecrolimus, used primarily for treating atopic dermatitis (eczema). Originally developed by Novartis, the rights to the brand were later acquired by various companies depending on the region. In many markets, including Spain as indicated by the 'Mylan Pharmaceuticals, S.L.' label, the brand became part of the Mylan portfolio.

Following a major industry merger in 2020, Mylan combined with Pfizer’s Upjohn division to form Viatris. Consequently, Viatris is the current ultimate owner of the brand. Manufacturing for such pharmaceutical products typically occurs in specialized facilities across Europe (such as Germany or Ireland) and the United States to meet global demand and regulatory standards.